(Q35845098)

10 August 2017

1 reference

title

Hazard ratio in clinical trials (English)

1 reference

10 August 2017

4

Matthew Samore

1 reference

10 August 2017

Spotswood L Spruance

1

1 reference

10 August 2017

Julia E Reid

series ordinal

2

1 reference

10 August 2017

Michael Grace

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

48

1 reference

10 August 2017

2787-2792

1 reference

10 August 2017

8

1 reference

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478551

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478551

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478551

Evaluating the yield of medical tests

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478551

Regression modelling strategies for improved prognostic prediction

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478551

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478551

Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15273082

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15273082

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.48.8.2787-2792.2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference